Fewer mitochondria in offspring of parents with diabetes

March 26, 2012
Fewer mitochondria in offspring of parents with diabetes
Normal-weight, insulin-resistant individuals whose parents have type 2 diabetes have fewer mitochondria in their muscles due to lower expression of lipoprotein lipase, according to a study published in the April issue of Diabetes.

(HealthDay) -- Normal-weight, insulin-resistant individuals whose parents have type 2 diabetes have fewer mitochondria in their muscles due to lower expression of lipoprotein lipase (LPL), according to a study published in the April issue of Diabetes.

Katsutaro Morino, from the Yale University School of Medicine in New Haven, Conn., and colleagues examined gene expression and their potential involvement in regulating mitochondrial biogenesis in skeletal muscle from 11 young, lean, insulin-resistant offspring of parents with type 2 diabetes and 11 insulin-sensitive subjects without a family history of type 2 diabetes.

The researchers found that the insulin-resistant subjects had significantly lower and of LPL in skeletal muscle, which was associated with reduced mitochondrial density. deficient in LPL had lower mitochondrial content due to reduced fatty acid delivery and reduced activation of the peroxisome proliferator-activated receptor-δ (PPAR-δ).

"Taken together, these data suggest that decreased mitochondrial content in muscle of insulin-resistant offspring may be due in part to reductions in LPL expression in skeletal muscle resulting in decreased PPAR-δ activation," Morino and colleagues conclude.

Explore further: Saturated fatty acids lead to mitochondrial dysfunction and insulin resistance

More information: Abstract
Full Text (subscription or payment may be required)


Related Stories

Saturated fatty acids lead to mitochondrial dysfunction and insulin resistance

January 20, 2012
Excessive levels of certain saturated fatty acids cause mitochondria to fragment, leading to insulin resistance in skeletal muscle, a precursor of type 2 diabetes, according to a paper in the January issue of the journal ...

Researchers identify new target for treatment of type 2 diabetes and prediabetes

August 22, 2011
Researchers at the Joslin Diabetes Center have shown that an enzyme found in the mitochondria of cells is decreased in the skeletal muscle of those with diabetes, a finding that could lead to the development of drugs to boost ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.